Annual Drug Patent Expirations for DOCETAXEL
Docetaxel is a drug marketed by Accord Hlthcare, Actavis Llc, Amneal, Apotex Inc, Dfb Oncology Ltd, Dr Reddys, Eugia Pharma, Gland Pharma Ltd, Hengrui Pharma, Hikma, Hospira Inc, Ingenus Pharms Llc, Meitheal, Mylan Labs Ltd, Pfizer Labs, Sandoz, Shilpa, Sun Pharm, Teva Pharms Usa, and Meridian Labs and, and is included in twenty-five NDAs. It is available from nineteen suppliers. There are four patents protecting this drug.
This drug has fifty-three patent family members in twenty-six countries.
The generic ingredient in DOCETAXEL is docetaxel. Nineteen suppliers are listed for this compound. Additional details are available on the docetaxel profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
